Endurance exercise in a rat model of metabolic syndrome.
We have measured the responses to endurance exercise training on body composition and glucose regulation, as well as cardiovascular and liver structure and function in rats fed a high carbohydrate and high fat (HCHF) diet as a model of human metabolic syndrome. Male Wistar rats (9-10 weeks old) were randomly allocated into corn starch (CS) or HCHF diet groups for 16 weeks; half of each group were exercised on a treadmill for 20, 25, and then 30 min/day, 5 days/week, during the last 8 weeks of the protocol. Metabolic, cardiovascular, and liver parameters were monitored. The HCHF diet induced symptoms of metabolic syndrome, including obesity, dyslipidemia, impaired glucose tolerance, and increased systolic blood pressure associated with the development of cardiovascular remodeling and nonalcoholic steatohepatitis. Exercise in HCHF rats decreased body mass, abdominal fat pads and circumference, blood glucose concentrations, plasma lipid profiles, systolic blood pressure, left ventricular diastolic stiffness, collagen deposition and inflammatory cell infiltration in the left ventricle, improved aortic contractile and relaxation responses, and decreased liver mass and hepatic fat accumulation. This study demonstrates that endurance exercise is effective in this rat model of diet-induced metabolic syndrome in improving body composition and glucose regulation, as well as cardiovascular and liver structure and function.
Department of Biological and Physical Sciences, University of Southern Queensland, Toowoomba, QLD 4350, Australia.
Isabelle
I
Cameron
Mohammad Ashraful
MA
Alam
Jianxiong
J
Wang
Lindsay
L
Brown
D000818:Animals; D001013:Aorta, Thoracic / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D001823:Body Composition; D002318:Cardiovascular Diseases / Q000209:etiology / Q000517:prevention & control; D059305:Diet, High-Fat / Q000009:adverse effects; D004040:Dietary Carbohydrates / Q000009:adverse effects; D004195:Disease Models, Animal; D050171:Dyslipidemias / Q000209:etiology / Q000517:prevention & control; D005234:Fatty Liver / Q000209:etiology / Q000517:prevention & control; D018149:Glucose Intolerance / Q000209:etiology / Q000517:prevention & control; D006352:Heart Ventricles / Q000276:immunology / Q000473:pathology / Q000503:physiopathology; D006973:Hypertension / Q000209:etiology / Q000517:prevention & control; D008099:Liver / Q000276:immunology / Q000473:pathology; D008297:Male; D024821:Metabolic Syndrome / Q000209:etiology / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D065626:Non-alcoholic Fatty Liver Disease; D009765:Obesity / Q000150:complications / Q000517:prevention & control; D005082:Physical Exertion; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar
D004040:Dietary Carbohydrates